Assure Holdings Corp. (IONM)
OTCMKTS · Delayed Price · Currency is USD
0.0480
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Assure Holdings Revenue
Assure Holdings had revenue of $1,000.00 in the quarter ending June 30, 2024, a decrease of -98.51%. This brings the company's revenue in the last twelve months to $-4.28M, up 369.26% year-over-year. In the year 2023, Assure Holdings had annual revenue of $-4.10M with 356.40% growth.
Revenue (ttm)
-4.28M
Revenue Growth
+369.26%
P/S Ratio
-0.04
Revenue / Employee
-45.00K
Employees
95
Market Cap
176.38K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | -4.10M | -3.20M | 356.40% |
Dec 31, 2022 | -899.00K | -30.09M | -103.08% |
Dec 31, 2021 | 29.19M | 25.67M | 728.38% |
Dec 31, 2020 | 3.52M | -14.20M | -80.12% |
Dec 31, 2019 | 17.73M | 2.91M | 19.67% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Assure Holdings News
- 11 months ago - Assure Announces Amendment of Exchange Offer Relating to its Convertible Notes - Business Wire
- 1 year ago - Assure Announces Extension of Exchange Offer Relating to its Convertible Notes - GlobeNewsWire
- 1 year ago - Assure Announces Reverse Stock Split to support Continued Listing on NASDAQ - GlobeNewsWire
- 1 year ago - Assure Holdings Receives Notification of Delinquency from Nasdaq - GlobeNewsWire
- 1 year ago - Assure & Danam Reschedule Corporate Update Call & Webcast - GlobeNewsWire
- 1 year ago - Assure Announces it will Remain Listed on the Nasdaq Capital Market Pursuant to Nasdaq Panel Decision - GlobeNewsWire
- 1 year ago - Assure Announces Approval of Increase in Authorized Capital at Adjourned Special Shareholders Meeting - GlobeNewsWire
- 1 year ago - Assure & Danam Postpone Corporate Update Call & Webcast Scheduled for May 16 - GlobeNewsWire